Gastric cancer: Prevention, screening and early diagnosis
Рак желудка: профилактика, скрининг и ранняя диагностика
2014-10-14
SCID: 54.1/cvfs8qnr
Discuss with AI
Endoscopic detectionGastric cancerGastric cancer screeningHelicobacter pylori eradicationOLGA and OLGIM classifications
Figures from the paper
Abstract (AI)
Gastric cancer continues to be an important healthcare problem from a global perspective. Most of the cases in the Western world are diagnosed at late stages when the treatment is largely ineffective. Helicobacter pylori (H. pylori) infection is a well-established carcinogen for gastric cancer. While lifestyle factors are important, the efficacy of interventions in their modification, as in the use of antioxidant supplements, is unconvincing. No organized screening programs can be found outside Asia (Japan and South Korea). Although several screening approaches have been proposed, including indirect atrophy detection by measuring pepsinogen in the circulation, none of them have so far been implemented, and more study data is required to justify any implementation. Mass eradication of H. pylori in high-risk areas tends to be cost-effective, but its adverse effects and resistance remain a concern. Searches for new screening biomarkers, including microRNA and cancer-autoantibody panels, as well as detection of volatile organic compounds in the breath, are in progress. Endoscopy with a proper biopsy follow-up remains the standard for early detection of cancer and related premalignant lesions. At the same time, new advanced high-resolution endoscopic technologies are showing promising results with respect to diagnosing mucosal lesions visually and targeting each biopsy. New histological risk stratifications (classifications), including OLGA and OLGIM, have recently been developed. This review addresses the current means for gastric cancer primary and secondary prevention, the available and emerging methods for screening, and new developments in endoscopic detection of early lesions of the stomach.
Key Findings
1
Endoscopy with appropriate biopsy follow-up remains the standard for detecting early gastric cancer and premalignant lesions, while advanced imaging, OLGA/OLGIM stratification, and emerging molecular or breath biomarkers show promise.
2
Gastric cancer is commonly diagnosed at late stages in Western countries, where treatment is largely ineffective.
3
Helicobacter pylori infection is an established gastric carcinogen, while evidence for lifestyle modification and antioxidant supplements remains unconvincing.
4
Mass H. pylori eradication may be cost-effective in high-risk regions, but adverse effects and antibiotic resistance remain important concerns.
5
Organized gastric cancer screening exists mainly in Japan and South Korea; proposed approaches such as circulating pepsinogen testing lack sufficient evidence for broader implementation.
Research Object
Gastric cancer and its premalignant gastric lesions in at-risk populations
Research Subject
Primary and secondary prevention, screening, and early-detection strategies, including risk stratification and endoscopic identification
Publication Details
Publication Date
2014-10-14
Journal
Publisher
ISSN
Cited by
480
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest